The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Respiratory Infectious Disease Diagnostics-Global Market Insights and Sales Trends 2025
Synopsis
Respiratory Infectious Disease Diagnostics mainly focuses on breathing issues and X-ray or CT scan to check the lower respiratory tract. Sometimes, fluid and inflammation in the lungs is also checked.
The global Respiratory Infectious Disease Diagnostics market size is expected to reach US$ 75130 million by 2029, growing at a CAGR of 2.2% from 2023 to 2029. The market is mainly driven by the significant applications of Respiratory Infectious Disease Diagnostics in various end use industries. The expanding demands from the Hospitals, Clinical Laboratories and Others,, are propelling Respiratory Infectious Disease Diagnostics market. Mechanical Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Imaging Tests segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Respiratory Infectious Disease Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Respiratory Infectious Disease Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Respiratory Infectious Disease Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Respiratory Infectious Disease Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Respiratory Infectious Disease Diagnostics covered in this report include Abbott Laboratories, Thermo Fisher Scientific., Koninklijke Philips, Cardinal Health, COSMED, Smiths Group, NIHON KOHDEN CORPORATION, Becton and Dickinson, etc.
The global Respiratory Infectious Disease Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Thermo Fisher Scientific.
Koninklijke Philips
Cardinal Health
COSMED
Smiths Group
NIHON KOHDEN CORPORATION
Becton
Dickinson
F.Hoffmann
bioMérieux SA
Bio-Rad Laboratories, Inc.
Quidel Corporation
Siemens Healthcare GmbH
Danaher
Qiagen
GENERAL ELECTRIC COMPANY
Medtronic
Novartis AG
Johnson & Johnson Services Inc
GlaxoSmithKline plc
Drägerwerk AG & Co. KGaA
GC Diagnostics Corporation
Bayer AG
Masimo
Carestream Health
Global Respiratory Infectious Disease Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Respiratory Infectious Disease Diagnostics market, Segment by Type:
Mechanical Tests
Imaging Tests
In Vitro Diagnostics (IVD) Tests
Global Respiratory Infectious Disease Diagnostics market, by Application
Hospitals
Clinical Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Respiratory Infectious Disease Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Respiratory Infectious Disease Diagnostics mainly focuses on breathing issues and X-ray or CT scan to check the lower respiratory tract. Sometimes, fluid and inflammation in the lungs is also checked.
The global Respiratory Infectious Disease Diagnostics market size is expected to reach US$ 75130 million by 2029, growing at a CAGR of 2.2% from 2023 to 2029. The market is mainly driven by the significant applications of Respiratory Infectious Disease Diagnostics in various end use industries. The expanding demands from the Hospitals, Clinical Laboratories and Others,, are propelling Respiratory Infectious Disease Diagnostics market. Mechanical Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Imaging Tests segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Respiratory Infectious Disease Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Respiratory Infectious Disease Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Respiratory Infectious Disease Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Respiratory Infectious Disease Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Respiratory Infectious Disease Diagnostics covered in this report include Abbott Laboratories, Thermo Fisher Scientific., Koninklijke Philips, Cardinal Health, COSMED, Smiths Group, NIHON KOHDEN CORPORATION, Becton and Dickinson, etc.
The global Respiratory Infectious Disease Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Thermo Fisher Scientific.
Koninklijke Philips
Cardinal Health
COSMED
Smiths Group
NIHON KOHDEN CORPORATION
Becton
Dickinson
F.Hoffmann
bioMérieux SA
Bio-Rad Laboratories, Inc.
Quidel Corporation
Siemens Healthcare GmbH
Danaher
Qiagen
GENERAL ELECTRIC COMPANY
Medtronic
Novartis AG
Johnson & Johnson Services Inc
GlaxoSmithKline plc
Drägerwerk AG & Co. KGaA
GC Diagnostics Corporation
Bayer AG
Masimo
Carestream Health
Global Respiratory Infectious Disease Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Respiratory Infectious Disease Diagnostics market, Segment by Type:
Mechanical Tests
Imaging Tests
In Vitro Diagnostics (IVD) Tests
Global Respiratory Infectious Disease Diagnostics market, by Application
Hospitals
Clinical Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Respiratory Infectious Disease Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Respiratory Infectious Disease Diagnostics
1.1 Respiratory Infectious Disease Diagnostics Market Overview
1.1.1 Respiratory Infectious Disease Diagnostics Product Scope
1.1.2 Respiratory Infectious Disease Diagnostics Market Status and Outlook
1.2 Global Respiratory Infectious Disease Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Respiratory Infectious Disease Diagnostics Market Size by Region (2018-2029)
1.4 Global Respiratory Infectious Disease Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Respiratory Infectious Disease Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Respiratory Infectious Disease Diagnostics Market Size (2018-2029)
1.6.1 North America Respiratory Infectious Disease Diagnostics Market Size (2018-2029)
1.6.2 Europe Respiratory Infectious Disease Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Respiratory Infectious Disease Diagnostics Market Size (2018-2029)
1.6.4 Latin America Respiratory Infectious Disease Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Respiratory Infectious Disease Diagnostics Market Size (2018-2029)
2 Respiratory Infectious Disease Diagnostics Market by Type
2.1 Introduction
2.1.1 Mechanical Tests
2.1.2 Imaging Tests
2.1.3 In Vitro Diagnostics (IVD) Tests
2.2 Global Respiratory Infectious Disease Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Respiratory Infectious Disease Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Respiratory Infectious Disease Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Respiratory Infectious Disease Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Respiratory Infectious Disease Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Respiratory Infectious Disease Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Respiratory Infectious Disease Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Respiratory Infectious Disease Diagnostics Revenue Breakdown by Type (2018-2029)
3 Respiratory Infectious Disease Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinical Laboratories
3.1.3 Others
3.2 Global Respiratory Infectious Disease Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Respiratory Infectious Disease Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Respiratory Infectious Disease Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Respiratory Infectious Disease Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Respiratory Infectious Disease Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Respiratory Infectious Disease Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Respiratory Infectious Disease Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Respiratory Infectious Disease Diagnostics Revenue Breakdown by Application (2018-2029)
4 Respiratory Infectious Disease Diagnostics Competition Analysis by Players
4.1 Global Respiratory Infectious Disease Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Respiratory Infectious Disease Diagnostics as of 2022)
4.3 Date of Key Players Enter into Respiratory Infectious Disease Diagnostics Market
4.4 Global Top Players Respiratory Infectious Disease Diagnostics Headquarters and Area Served
4.5 Key Players Respiratory Infectious Disease Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Respiratory Infectious Disease Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.1.4 Abbott Laboratories Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Thermo Fisher Scientific.
5.2.1 Thermo Fisher Scientific. Profile
5.2.2 Thermo Fisher Scientific. Main Business
5.2.3 Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.2.4 Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific. Recent Developments
5.3 Koninklijke Philips
5.3.1 Koninklijke Philips Profile
5.3.2 Koninklijke Philips Main Business
5.3.3 Koninklijke Philips Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.3.4 Koninklijke Philips Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Cardinal Health Recent Developments
5.4 Cardinal Health
5.4.1 Cardinal Health Profile
5.4.2 Cardinal Health Main Business
5.4.3 Cardinal Health Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.4.4 Cardinal Health Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Cardinal Health Recent Developments
5.5 COSMED
5.5.1 COSMED Profile
5.5.2 COSMED Main Business
5.5.3 COSMED Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.5.4 COSMED Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 COSMED Recent Developments
5.6 Smiths Group
5.6.1 Smiths Group Profile
5.6.2 Smiths Group Main Business
5.6.3 Smiths Group Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.6.4 Smiths Group Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Smiths Group Recent Developments
5.7 NIHON KOHDEN CORPORATION
5.7.1 NIHON KOHDEN CORPORATION Profile
5.7.2 NIHON KOHDEN CORPORATION Main Business
5.7.3 NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.7.4 NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 NIHON KOHDEN CORPORATION Recent Developments
5.8 Becton
5.8.1 Becton Profile
5.8.2 Becton Main Business
5.8.3 Becton Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.8.4 Becton Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Becton Recent Developments
5.9 Dickinson
5.9.1 Dickinson Profile
5.9.2 Dickinson Main Business
5.9.3 Dickinson Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.9.4 Dickinson Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Dickinson Recent Developments
5.10 F.Hoffmann
5.10.1 F.Hoffmann Profile
5.10.2 F.Hoffmann Main Business
5.10.3 F.Hoffmann Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.10.4 F.Hoffmann Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 F.Hoffmann Recent Developments
5.11 bioMérieux SA
5.11.1 bioMérieux SA Profile
5.11.2 bioMérieux SA Main Business
5.11.3 bioMérieux SA Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.11.4 bioMérieux SA Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 bioMérieux SA Recent Developments
5.12 Bio-Rad Laboratories, Inc.
5.12.1 Bio-Rad Laboratories, Inc. Profile
5.12.2 Bio-Rad Laboratories, Inc. Main Business
5.12.3 Bio-Rad Laboratories, Inc. Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.12.4 Bio-Rad Laboratories, Inc. Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 Bio-Rad Laboratories, Inc. Recent Developments
5.13 Quidel Corporation
5.13.1 Quidel Corporation Profile
5.13.2 Quidel Corporation Main Business
5.13.3 Quidel Corporation Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.13.4 Quidel Corporation Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 Quidel Corporation Recent Developments
5.14 Siemens Healthcare GmbH
5.14.1 Siemens Healthcare GmbH Profile
5.14.2 Siemens Healthcare GmbH Main Business
5.14.3 Siemens Healthcare GmbH Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.14.4 Siemens Healthcare GmbH Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 Siemens Healthcare GmbH Recent Developments
5.15 Danaher
5.15.1 Danaher Profile
5.15.2 Danaher Main Business
5.15.3 Danaher Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.15.4 Danaher Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.15.5 Danaher Recent Developments
5.16 Qiagen
5.16.1 Qiagen Profile
5.16.2 Qiagen Main Business
5.16.3 Qiagen Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.16.4 Qiagen Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.16.5 Qiagen Recent Developments
5.17 GENERAL ELECTRIC COMPANY
5.17.1 GENERAL ELECTRIC COMPANY Profile
5.17.2 GENERAL ELECTRIC COMPANY Main Business
5.17.3 GENERAL ELECTRIC COMPANY Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.17.4 GENERAL ELECTRIC COMPANY Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.17.5 GENERAL ELECTRIC COMPANY Recent Developments
5.18 Medtronic
5.18.1 Medtronic Profile
5.18.2 Medtronic Main Business
5.18.3 Medtronic Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.18.4 Medtronic Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.18.5 Medtronic Recent Developments
5.19 Novartis AG
5.19.1 Novartis AG Profile
5.19.2 Novartis AG Main Business
5.19.3 Novartis AG Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.19.4 Novartis AG Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.19.5 Novartis AG Recent Developments
5.20 Johnson & Johnson Services Inc
5.20.1 Johnson & Johnson Services Inc Profile
5.20.2 Johnson & Johnson Services Inc Main Business
5.20.3 Johnson & Johnson Services Inc Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.20.4 Johnson & Johnson Services Inc Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.20.5 Johnson & Johnson Services Inc Recent Developments
5.21 GlaxoSmithKline plc
5.21.1 GlaxoSmithKline plc Profile
5.21.2 GlaxoSmithKline plc Main Business
5.21.3 GlaxoSmithKline plc Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.21.4 GlaxoSmithKline plc Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.21.5 GlaxoSmithKline plc Recent Developments
5.22 Drägerwerk AG & Co. KGaA
5.22.1 Drägerwerk AG & Co. KGaA Profile
5.22.2 Drägerwerk AG & Co. KGaA Main Business
5.22.3 Drägerwerk AG & Co. KGaA Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.22.4 Drägerwerk AG & Co. KGaA Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.22.5 Drägerwerk AG & Co. KGaA Recent Developments
5.23 GC Diagnostics Corporation
5.23.1 GC Diagnostics Corporation Profile
5.23.2 GC Diagnostics Corporation Main Business
5.23.3 GC Diagnostics Corporation Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.23.4 GC Diagnostics Corporation Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.23.5 GC Diagnostics Corporation Recent Developments
5.24 Bayer AG
5.24.1 Bayer AG Profile
5.24.2 Bayer AG Main Business
5.24.3 Bayer AG Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.24.4 Bayer AG Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.24.5 Bayer AG Recent Developments
5.25 Masimo
5.25.1 Masimo Profile
5.25.2 Masimo Main Business
5.25.3 Masimo Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.25.4 Masimo Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.25.5 Masimo Recent Developments
5.26 Carestream Health
5.26.1 Carestream Health Profile
5.26.2 Carestream Health Main Business
5.26.3 Carestream Health Respiratory Infectious Disease Diagnostics Products, Services and Solutions
5.26.4 Carestream Health Respiratory Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.26.5 Carestream Health Recent Developments
6 North America
6.1 North America Respiratory Infectious Disease Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Respiratory Infectious Disease Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Infectious Disease Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Respiratory Infectious Disease Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Infectious Disease Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Respiratory Infectious Disease Diagnostics Market Dynamics
11.1 Respiratory Infectious Disease Diagnostics Industry Trends
11.2 Respiratory Infectious Disease Diagnostics Market Drivers
11.3 Respiratory Infectious Disease Diagnostics Market Challenges
11.4 Respiratory Infectious Disease Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
